Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses

被引:53
|
作者
Khella, Heba W. Z. [1 ,2 ,3 ]
White, Nicole M. A. [1 ,2 ,4 ]
Faragalla, Hala [1 ,2 ,4 ]
Gabril, Manal [5 ]
Boazak, Mina [1 ,2 ]
Dorian, David [1 ,2 ]
Khalil, Bishoy [1 ,2 ]
Antonios, Hany [1 ,2 ]
Bao, Tian Tian [1 ,2 ]
Pasic, Maria D. [4 ]
Honey, R. John [6 ]
Stewart, Robert [6 ]
Pace, Kenneth T. [6 ]
Bjarnason, Georg A. [7 ]
Jewett, Michael A. S. [8 ]
Yousef, George M. [1 ,2 ,4 ]
机构
[1] St Michaels Hosp, Li Ka Shing Knowledge Inst, Dept Lab Med, Toronto, ON M5B 1W8, Canada
[2] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada
[3] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada
[4] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada
[5] London Hlth Sci Ctr, Dept Pathol, London, ON N6A 5W9, Canada
[6] St Michaels Hosp, Div Urol, Toronto, ON M5B 1W8, Canada
[7] Sunnybrook Odette Canc Ctr, Div Med Oncol & Hematol, Toronto, ON M4N 3M5, Canada
[8] Univ Toronto, Univ Hlth Network, Princess Margaret Hosp, Dept Surg,Div Urol Oncol, Toronto, ON M5S 1A8, Canada
关键词
Renal cell carcinoma; VEGF-A; MicroRNA; Tumour markers; Metastasis; Prognosis; ADHESION KINASE GENE; TUMOR-SUPPRESSOR; NONCODING RNA; CANCER; MICRORNAS; EXPRESSION; GROWTH; OVEREXPRESSION; IDENTIFICATION; INVASIVENESS;
D O I
10.1007/s13277-011-0255-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Metastasis results in most of the cancer deaths in clear cell renal cell carcinoma (ccRCC). MicroRNAs (miRNAs) regulate many important cell functions and play important roles in tumor development, metastasis and progression. In our previous study, we identified a miRNA signature for metastatic RCC. In this study, we validated the top differentially expressed miRNAs on matched primary and metastatic ccRCC pairs by quantitative polymerase chain reaction. We performed bioinformatics analyses including target prediction and combinatorial analysis of previously reported miRNAs involved in tumour progression and metastasis. We also examined the co-expression of the miRNAs clusters and compared expression of intronic miRNAs and their host genes. We observed significant dysregulation between primary and metastatic tumours from the same patient. This indicates that, at least in part, the metastatic signature develops gradually during tumour progression. We identified metastasis-dysregulated miRNAs that can target a number of genes previously found to be involved in metastasis of kidney cancer as well as other malignancies. In addition, we found a negative correlation of expression of miR-126 and its target vascular endothelial growth factor (VEGF)-A. Cluster analysis showed that members of the same miRNA cluster follow the same expression pattern, suggesting the presence of a locus control regulation. We also observed a positive correlation of expression between intronic miRNAs and their host genes, thus revealing another potential control mechanism for miRNAs. Many of the significantly dysregulated miRNAs in metastatic ccRCC are highly conserved among species. Our analysis suggests that miRNAs are involved in ccRCC metastasis and may represent potential biomarkers.
引用
收藏
页码:131 / 140
页数:10
相关论文
共 50 条
  • [21] miRNAs in melanoma: a defined role in tumor progression and metastasis
    Mannavola, Francesco
    Tucci, Marco
    Felici, Claudia
    Stucci, Stefania
    Silvestris, Franco
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (01) : 79 - 89
  • [22] Apolipoprotein L1 is a tumor suppressor in clear cell renal cell carcinoma metastasis
    Le, Linh Nguy-Hoang
    Choi, Cheolwon
    Han, Jae-A.
    Kim, Eun-Bit
    Trinh, Van Ngu
    Kim, Yong-June
    Ryu, Seongho
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [23] Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma
    Heinzelmann, Joana
    Henning, Brenda
    Sanjmyatav, Jimsgene
    Posorski, Nicole
    Steiner, Thomas
    Wunderlich, Heiko
    Gajda, Mieczyslaw R.
    Junker, Kerstin
    WORLD JOURNAL OF UROLOGY, 2011, 29 (03) : 367 - 373
  • [24] The role of surgery in renal cell carcinoma with pancreatic metastasis
    Chang, Ying-Hsu
    Liaw, Chuang-Chi
    Chuang, Cheng-Keng
    BIOMEDICAL JOURNAL, 2015, 38 (02) : 173 - 176
  • [25] Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma
    Wang, Chao
    Li, Yan
    Chu, Chuan-min
    Zhang, Xiang-min
    Ma, Jie
    Huang, Hai
    Wang, Yu-ning
    Hong, Tian-yu
    Zhang, Jing
    Pan, Xiu-wu
    Zheng, Jing-cun
    Jiang, Ning
    Hu, Chuan-yi
    Ma, Xiaojing
    Sun, Ying-hao
    Cui, Xin-gang
    EBIOMEDICINE, 2019, 39 : 255 - 264
  • [26] Expression of DLC-1 in Clear Cell Renal Cell Carcinoma: Prognostic Significance for Progression and Metastasis
    Zhang, Tao
    Zheng, Jingcun
    Liu, Chunfang
    Lu, Yuan
    UROLOGIA INTERNATIONALIS, 2009, 82 (04) : 380 - 387
  • [27] TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma
    Pan, Qiufeng
    Cheng, Gong
    Liu, Yuenan
    Xu, Tianbo
    Zhang, Hao
    Li, Bing
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2020, 56 (05) : 1101 - 1114
  • [28] A genome-wide comprehensively analyses of long noncoding RNA profiling and metastasis associated lncRNAs in renal cell carcinoma
    Xu, Xue
    Xu, Yongcan
    Shi, Chuanqin
    Wang, Baoyu
    Yu, Xiang
    Zou, Yanfen
    Hu, Tao
    ONCOTARGET, 2017, 8 (50) : 87773 - 87781
  • [29] Risk of metastasis for T1a renal cell carcinoma
    Lee, Hakmin
    Lee, Jung Keun
    Kim, Kwangmo
    Kwak, Cheol
    Kim, Hyeon Hoe
    Byun, Seok-Soo
    Lee, Sang Eun
    Hong, Sung Kyu
    WORLD JOURNAL OF UROLOGY, 2016, 34 (04) : 553 - 559
  • [30] Potential prognostic value of miRNAs as biomarker for progression and recurrence after nephrectomy in renal cell carcinoma: a literature review
    Fasanella, Daniela
    Antonaci, Alessio
    Esperto, Francesco
    Scarpa, Roberto M.
    Ferro, Matteo
    Schips, Luigi
    Marchioni, Michele
    DIAGNOSIS, 2022, 9 (02) : 157 - 165